Status:
COMPLETED
Healthy, Immunized Communities Study
Lead Sponsor:
Milton S. Hershey Medical Center
Collaborating Sponsors:
Merck Sharp & Dohme LLC
Conditions:
Vaccine Hesitancy
Communicable Diseases in Children
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This project aims to understand how improving vaccine education and awareness can impact the number of parents who vaccinate, or intend to vaccine, their middle school-aged children with age-appropria...
Detailed Description
Vaccines are considered one of the greatest public health successes. Unfortunately, an increasing rate of parental resistance in recent years has led to a reemergence of vaccine-preventable diseases. ...
Eligibility Criteria
Inclusion
- Inclusion Criteria
- 18 years or older
- Parents and guardians of children who attend a School District of Lancaster middle schools
- Individuals who read and understand English
- Individuals with an email address
- Exclusion Criteria
- Individuals who are non-English speaking
- Parents/Guardians \<18 years or older who do not have children attending a middle school in the School District of Lancaster
- Individuals who do not have an email address
- Individuals who plan on moving out of the Lancaster City area in the next year
Exclusion
Key Trial Info
Start Date :
February 14 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 9 2023
Estimated Enrollment :
148 Patients enrolled
Trial Details
Trial ID
NCT03854734
Start Date
February 14 2019
End Date
February 9 2023
Last Update
July 12 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Penn State College of Medicine
Hershey, Pennsylvania, United States, 17033